NeuBase Therapeutics, Inc. has appointed industry veteran William Mann, Ph.D., MBA as chief operating officer. Dr. Mann will leverage his decades of experience in the biopharma industry to manage NeuBase operations and advance its strategic goals. Most recently, he served as the president and chief executive officer of Helsinn Therapeutics (U.S.), Inc. Before joining Helsinn, he held multiple positions at Sapphire Therapeutics, Inc., rising to vice president of corporate development, where h...